Drugs.com
JULY 27, 2024
SATURDAY, July 27, 2024 -- As scorching temperatures continue to plague the United States this summer, millions of Americans are at risk for dehydration and heat-linked illness.But what about their medications? Can rising temperatures render those.
Drug Patent Watch
JULY 27, 2024
This chart shows the pharmaceutical companies with the most patents in South Africa. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
Perficient: Drug Development
JULY 27, 2024
Welcome to the next installment in our UX in Universal Design series! This edition focuses on the key principles of usability for keyboard access specifically tailored for individuals with physical disabilities within health systems. Ensuring that healthcare digital interfaces are accessible via keyboard navigation is crucial for providing equitable care and improving patient outcomes.
Drug Patent Watch
JULY 27, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Perficient: Drug Development
JULY 27, 2024
Welcome to another installment in our UX in Universal Design series! This edition focuses on the key principles of usability for voice control and speech recognition specifically tailored for individuals with physical disabilities within health systems. Voice control and speech recognition technologies are essential tools for enhancing accessibility and improving patient experiences.
Drug Patent Watch
JULY 27, 2024
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.
Drug Patent Watch
JULY 27, 2024
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in two NDAs. It is available from one supplier.
Expert insights. Personalized for you.
105 
Let's personalize your content